First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy

Pregnancy Hypertension

Volumn 3, Issue 4, 2013, Pages 215-221

  Schneuer, Francisco J ^a   Nassar, Natasha ^a   Guilbert, Cyrille ^a   Tasevski, Vitomir ^b   Ashton, Anthony W ^a   Morris, Jonathan M ^a   Roberts, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

First trimester; Fms like tyrosine kinase 1; Placental growth factor; Pre eclampsia; Predictive accuracy; Pregnancy hypertension

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; AUSTRALIA; COHORT ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL WELFARE; NULLIPARA; PARITY; PATHOGENESIS; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 84888639586     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2013.04.119     Document Type: Article

References (37)

1. K.S. Khan, D. Wojdyla, L. Say, A.M. Gulmezoglu, and P.F. VanLook WHO analysis of causes of maternal death: a systematic review Lancet 367 9516 2006 1066 1074
2. E.A. Steegers, P. Von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 9741 2010 631 644
3. M. Coolman, S. Timmermans, C.J. de Groot, H. Russcher, J. Lindemans, and A. Hofman Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes Obstet Gynecol 119 6 2012 1190 1200
4. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 9461 2005 785 799
5. K. Duckitt, and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 7491 2005 565
6. C.E. Kleinrouweler, M.M. Wiegerinck, C. Ris-Stalpers, P.M. Bossuyt, J.A. Van der Post, and P. Von Dadelszen Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis Bjog 119 7 2012 778 787
7. S.J. Lain, C.S. Algert, V. Tasevski, J.M. Morris, and C.L. Roberts Record linkage to obtain birth outcomes for the evaluation of screening tests in pregnancy: a feasibility study BMC Medical Research Methods. 9 2009 48
8. Centre for Health Record Linkage. Quality assurance in record linkage. < http://wwwcherelorgau/CHeReLQualityAssuranceJuly2008pdf > 2009.
9. N. Meray, J.B. Reitsma, A.C. Ravelli, and G.J. Bonsel Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number J Clin Epidemiol 60 9 2007 883 891
10. M.T. Lydon-Rochelle, V.L. Holt, V. Cardenas, J.C. Nelson, T.R. Easterling, and C. Gardella The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data Am J Obstet Gynecol 193 1 2005 125 134
11. C.L. Roberts, J.C. Bell, J.B. Ford, R.M. Hadfield, C.S. Algert, and J.M. Morris The accuracy of reporting of the hypertensive disorders of pregnancy in population health data Hypertens Pregnancy 27 3 2008 285 297
12. Australian Bureau of Statistics. Census of population and housing: socio-economic indexes for areas (SEIFA). Available from: < http://wwwabsgovau/ausstats/abs@nsf/mf/2033055001/ >; 2006 [accessed 10.03.11].
13. S.J. Lain, R.M. Hadfield, C.H. Raynes-Greenow, J.B. Ford, N.M. Mealing, and C.S. Algert Quality of data in perinatal population health databases: a systematic review Med Care 50 4 2012 e7 e20
14. J.L. Schafer, and M.K. Olsen Multiple imputation for multivariate missing-data problems: a data analyst's perspective Multivar Behav Res 33 4 1998 545 571
15. H. Cuckle, and N.J. Wald Principles of screening N. Wald, I. Leck, Antenatal and neonatal screening second ed. 2000 Oxford University Press Oxford, UK 3 22
16. J.A. Swets Measuring the accuracy of diagnostic systems Science 240 4857 1988 1285 1293
17. K. Koga, Y. Osuga, T. Tajima, Y. Hirota, T. Igarashi, and T. Fujii Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole Fertil Steril 94 1 2010 305 308
18. A.M. Lynch, J.R. Murphy, R.S. Gibbs, R.J. Levine, P.C. Giclas, and J.E. Salmon The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia Bjog 117 4 2010 456 462
19. M. Parra, R. Rodrigo, P. Barja, C. Bosco, V. Fernandez, and H. Munoz Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction Am J Obstet Gynecol 193 4 2005 1486 1491
20. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672 683
21. M. Zwahlen, S. Gerber, and N.A. Bersinger First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels Gynecol Obstet Invest 63 1 2007 15 21
22. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 1 2003 177 182
23. M.U. Baumann, N.A. Bersinger, M.G. Mohaupt, L. Raio, S. Gerber, and D.V. Surbek First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia Am J Obstet Gynecol 199 3 2008 e1 e6 [266]
24. T.F. McElrath, K.H. Lim, E. Pare, J. Rich-Edwards, D. Pucci, and R. Troisi Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic actors through pregnancy Am J Obstet Gynecol 207 5 2012 e1 e7 [407]
25. B.M. Sibai, M.A. Koch, S. Freire, J.L. Pinto e Silva, M.V. Rudge, and S. Martins-Costa Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 199 3 2008 e1 e9 [268]
26. R. Akolekar, E. Zaragoza, L.C. Poon, S. Pepes, and K.H. Nicolaides Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia Ultrasound Obstet Gynecol 32 6 2008 732 739
27. A. Youssef, F. Righetti, D. Morano, N. Rizzo, and A. Farina Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (>34 weeks) pre-eclampsia Prenat Diagn 31 12 2011 1141 1146
28. J. Yu, C.Z. Shixia, Y. Wu, and T. Duan Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia Ultrasound Obstet Gynecol 37 5 2011 528 533
29. E.J. Wortelboer, M.P. Koster, H.S. Cuckle, P.H. Stoutenbeek, P.C. Schielen, and G.H. Visser First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia Bjog 117 11 2010 1384 1389
30. F. Audibert, I. Boucoiran, N. An, N. Aleksandrov, E. Delvin, and E. Bujold Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women Am J Obstet Gynecol 203 4 2010 e1 e8 [383]
31. L. Myatt, R.G. Clifton, J.M. Roberts, C.Y. Spong, J.C. Hauth, and M.W. Varner First-trimester prediction of preeclampsia in nulliparous women at low risk Obstet Gynecol 119 6 2012 1234 1242
32. Myers JE, Kenny LC, McCowan LME, Chan EHY, Dekker GA, Poston L, Simpson NAB and North RA. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. Bjog. 2013. http://dx.doi.org/10.1111/1471-0528.12195.
33. O. Lapaire, A. Shennan, and H. Stepan The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application Eur J Obstet Gynecol Reprod Biol 151 2 2010 122 129
34. S. Thangaratinam, E. Rogozinska, K. Jolly, S. Glinkowski, T. Roseboom, and J.W. Tomlinson Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence Bmj 344 2012 e2088
35. L.M. Askie, L. Duley, D.J. Henderson-Smart, and L.A. Stewart Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet 369 9575 2007 1791 1798
36. J.J. Deeks, and D.G. Altman Diagnostic tests 4: likelihood ratios Bmj 329 7458 2004 168 169
37. Centre for Epidemiology and Research NSW department of health. NSW mothers and babies 2007 2010 NSW Public Health Bull [vol. 21(S1), p. 1-156]